Jump to navigation
The latest clinical and political news for Australian Rheumatologists
It leads to cartilage loss with no significant improvement in pain.
And it has other benefits too
Benefits are in few and shortlived
And it's not just in people with osteophytes
Seven developments in the specialty this week
From acupressure in knee osteoarthritis to the risks of psoriatic arthritis.
And with modern drugs the effect may be even greater.
Lowering serum urate is key.
Six developments you should know about
Spinal manipulation is as good as NSAIDs for low back pain
New tax data suggests they earn less than half of the most lucrative medical specialities.
A new study should allay fears about treating gout with high doses of allopurinol.
Update contains several revisions based on expert input from 20 rheumatologists.
And it has been 'a' flagged.
MSD's new drug joins those from Janssen and Pfizer.
Pain levels over eight weeks were similar regardless of what patients took.
A paradigm shift hasn't entirely been driven by biologics.
It's just as good as guided rehabilitation at home, a Sydney study shows.
The first update in seven years clarifies recommendations on investigations and treatments.
We chat with rheumatologist David Hunter.
Australian Doctor Group is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.